Published in Proc Natl Acad Sci U S A on March 01, 1989
Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro. J Physiol (1994) 0.85
Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats. Neuroscience (2012) 0.84
Rostroventral caudate putamen involvement in ethanol withdrawal is influenced by a chromosome 4 locus. Genes Brain Behav (2010) 0.81
Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous system. Brain Res (1967) 3.16
Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science (1982) 1.60
Epilepsy and gamma-aminobutyric acid-mediated inhibition. Int Rev Neurobiol (1975) 1.42
A crucial epileptogenic site in the deep prepiriform cortex. Nature (1985) 1.36
Evidence implicating substantia nigra in regulation of kindled seizure threshold. J Neurosci (1984) 1.28
Convulsant hydrazides. I. In vitro and in vivo inhibition of vitamin B6 enzymes by convulsant hydrazides. J Pharmacol Exp Ther (1957) 1.22
Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia (1984) 1.03
Glutamate decarboxylase-immunoreactive structures in the rat neostriatum: a correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry. J Comp Neurol (1985) 0.95
Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci U S A (1987) 0.89
Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioural and morphological analysis. Neuroscience (1985) 0.84
2-Amino-7-phosphonoheptanoic acid (2-APH) infusion into entopeduncular nucleus protects against limbic seizures in rats. Neurosci Lett (1986) 0.84
Intrastriatal N-methyl-D-aspartate prevents amygdala kindled seizures in rats. Brain Res (1986) 0.82
The efferent pathway of epileptic seizures for the face following cortical stimulation differs from that for limbs. Jpn J Physiol (1953) 0.80
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron (2000) 2.56
Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46
Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse (1989) 2.23
Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (2001) 2.17
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia (1994) 2.05
Prevalence of antigliadin antibodies in ataxia patients. Neurology (2003) 1.89
Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A (2001) 1.88
Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature (1993) 1.81
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol (2001) 1.67
Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res (1984) 1.59
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci (1989) 1.57
Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia (1992) 1.57
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
The role of GSK-3 in synaptic plasticity. Br J Pharmacol (2008) 1.52
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand (2003) 1.51
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
New insights from the use of pilocarpine and kainate models. Epilepsy Res (2002) 1.42
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia (1999) 1.39
Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families. Neurology (1999) 1.39
Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis (2001) 1.36
MRI findings in Hirayama's disease: flexion-induced cervical myelopathy or intrinsic motor neuron disease? J Neurol (1999) 1.36
The aetiology of sporadic adult-onset ataxia. Brain (2002) 1.34
Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cereb Cortex (1999) 1.34
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron (2001) 1.27
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology (1998) 1.25
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci (2000) 1.25
Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol (1999) 1.24
Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis (2000) 1.24
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet (1997) 1.24
Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol (1999) 1.23
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res (1987) 1.20
N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A (1999) 1.20
Cholinomimetics produce seizures and brain damage in rats. Experientia (1983) 1.18
Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp Brain Res (1995) 1.18
An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol (1998) 1.17
Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology (2010) 1.15
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J Neurosci (1998) 1.14
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem (2001) 1.13
Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res (1996) 1.10
Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci Biobehav Rev (1990) 1.10
Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.10
Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol (1982) 1.09
Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res (1999) 1.08
Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain (1996) 1.07
Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res (1995) 1.07
Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis? AJNR Am J Neuroradiol (2006) 1.06
The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem (1997) 1.06
Identification of inhibitor-of-differentiation 2 (Id2) as a modulator of neuronal apoptosis. J Neurochem (2002) 1.06
Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. Cell Death Differ (2004) 1.05
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry (2004) 1.05
Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage (2007) 1.04
Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. J Neurooncol (2000) 1.04
Antiepileptic drugs and the developing brain. Cell Mol Life Sci (2006) 1.04
Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol (2003) 1.04
SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. Hum Mol Genet (1997) 1.04
The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res (1999) 1.03
Synaptic activation of a presynaptic kainate receptor facilitates AMPA receptor-mediated synaptic transmission at hippocampal mossy fibre synapses. Neuropharmacology (2001) 1.02
The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol J Pharmacol Pharm (1989) 1.02
Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect (2000) 1.01
Prospective analysis of falls in dominant ataxias. Eur Neurol (2012) 1.00
Age-related changes in kynurenic acid production in rat brain. Brain Res (1992) 1.00
In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum. J Neurosci (1986) 1.00
Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J Neuroimmunol (1999) 1.00
SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology (2008) 1.00
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology (2005) 0.99
Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience (1986) 0.99
A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices. Br J Pharmacol (2000) 0.99
Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species. J Neurochem (1997) 0.98
Cognitive deficits in spinocerebellar ataxia 2. Brain (1999) 0.98
Sporadic adult onset ataxia of unknown etiology : a clinical, electrophysiological and imaging study. J Neurol (2007) 0.98
Effect of physical exercise on seizure occurrence in a model of temporal lobe epilepsy in rats. Epilepsy Res (1999) 0.98
EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Eur J Neurol (2014) 0.97